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6. Johnson, J. R., O'Bryan, T. T., Low, D. A. et al. (2000) . Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III. Infection and Immunity 68, 3327-36. Sir, The ability of Staphylococcus aureus to adhere to surfaces of host tissues is thought to be essential for colonization and establishment of infections. 1 There is increasing evidence that subinhibitory concentrations of antibiotics interfere with microbial adherence to host cells. In this study, the effect of subinhibitory concentrations of the fluorinated chloramphenicol derivative florfenicol on adherence properties of florfenicol-susceptible and florfenicol-resistant S. aureus was investigated.
The florfenicol-susceptible strain S. aureus Newman (ATCC 25904) and its florfenicol-resistant derivative carrying the cfr-erm(33)-spc multiresistance plasmid pSCFS1 from Staphylococcus sciuri 2 were cultivated for 20 h at 378C in brain heart infusion broth (BHI, Oxoid, Wesel, Germany) and in BHI supplemented with either 0.2 mg/L florfenicol (Essex Tierarznei, Munich, Germany) or 2 mg/L florfenicol ( = 1/20 and 1/2 MIC for S. aureus Newman, respectively). In addition, S. aureus Newman:pSCFS1 was cultivated in BHI supplemented with 64 mg/L florfenicol ( = 1/2 MIC for S. aureus Newman:pSCFS1). MICs of florfenicol were determined by broth microdilution according to the NCCLS guideline M31-A2.
3 Adherence and invasion assays using 5 Â 10 6 bacteria per experiment and confluent monolayers of HEp-2 cells ($ 3 Â 10 5 cells per well) were carried out as described by Dziewanowska et al. 4 The results were recorded as percentage of cfu of adherent or intracellular bacteria. For microscopic confirmation, adherence assays were carried out on culture slides containing $ 2 Â 10 5 HEp-2 cells. Washed monolayers with adherent bacteria were fixed with 0.37% formaldehyde (Sigma, Taufkirchen, Germany) at 48C, washed with PBS and covered with blocking buffer [10% fetal calf serum (Sigma) in PBS] for 1 h. Adherent staphylococci were detected by use of a rabbit-anti-staphylococcal antibody, an FITC-conjugated goat-anti-rabbit IgG antibody (Dianova, Hamburg, Germany) and subsequent immunofluorescence microscopy. Bacteria-per-epithelial cell ratios were determined by counting manually the number of bacteria adherent to epithelial cells in three microscopic fields with $ 50 epithelial cells per field.
Growth in the presence of low subinhibitory concentrations of florfenicol, such as 0.2 mg/L for S. aureus Newman as well as 0.2 and 2 mg/L for S. aureus Newman:pSCFS1, did not change significantly the adherence patterns of both strains compared with the untreated controls. However, when grown in the presence of the strain-specific 1/2 MIC, both strains adhered significantly better (P < _ 0.05) to HEp-2 cells (Table 1) . Although invasion also increased significantly when the bacteria were treated with the strain-specific 1/2 MIC, the percentages of invading bacteria ranged between 0.1% and 0.28% (Table 1) and thus were negligible in view of the percentages of adherent bacteria. This observation was in good accordance with that of Dziewanowska et al. 4 who showed that S. aureus strain Newman is less invasive than other S. aureus strains which exhibit comparable adherence to epithelial cells. Thus, virtually all bacteria detected after release from the epithelial cells could be considered as truly adherent bacteria. Quantification of the adherent bacteria per epithelial cell by immunochemical microscopic evaluation yielded results that correlated well with those obtained by the plating technique. A four-fold increase in the number of adherent bacteria per epithelial cell was detected in case of the florfenicol-susceptible S. aureus Newman whereas an eight-fold increase was seen in the case of the florfenicol-resistant S. aureus Newman:pSCFS1 (Table 1) .
Bacterial adhesion can be the result of either hydrophobic interactions between the bacteria and the host cells, binding of bacteria to specific ligands, e.g. fibronectin, or a combination of both. Therefore, florfenicol-treated staphylococci and untreated controls were investigated for their surface hydrophobicity by a hydrocarbon adherence assay 5 and for their ability to bind to fibronectin-coated micotitre plates (1 mg of fibronectin per well). 4 Independently of the florfenicol concentration used, both strains showed a non-significant decrease in their surface hydrophobicity (Table 1 ). In contrast, the fibronectin-binding profiles of both strains grown in the presence of the strain-specific 1/2 MIC of florfenicol exhibited significant four-to five-fold increases (Table 1) . Based on this finding, we assume that binding to fibronectin plays a relevant role in the increased adherence of the staphylococci to HEp-2 cells, rather than nonspecific hydrophobic interactions.
The observations made in this study differ from those of a previous study on tetracycline-treated S. aureus in which increased adherence was directly correlated with significantly increased hydrophobicity.
6 However, the results of our study also showed parallels to a study in which pretreatment of S. aureus with sub-MIC levels of ciprofloxacin gave an induced expression of fibronectin binding proteins and also resulted in increased adhesion of the staphylococci.
7 Although further work is needed to elucidate the mechanisms leading to the observed changes in the adherence patterns, our data demonstrate that florfenicol concentrations in the range of strain-specific 1/2 MIC enhance the adherence of florfenicol-susceptible and also florfenicol-resistant S. aureus to epithelial cells, and thus may alter virulence properties of this pathogen. 5. Rosenberg, M., Gutnick, D. & Rosenberg, E. (1980) . Adherence of bacteria to hydrocarbons: a simple method for measuring cellsurface hydrophobicity. FEMS Microbiology Letters 9, 29-33.
6. Schwarz, S. (1994) . Increased cell wall thickness and its effects on potential virulence properties of tetracycline-resistant Staphylococcus aureus. Medical Microbiology Letters 3, 16-22.
7. Bisognano, C., Vaudaux, P., Rohner, P. et al. (2000) . Induction of fibronectin-binding proteins and increased adhesion of quinoloneresistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrobial Agents and Chemotherapy 44, 1428-37. 1 Glatiramer (copolymer 1; COPA-XONE), a mixed, random polymer of Ala, Glu, Lys and Tyr used in the treatment of relapsing-remitting multiple sclerosis 2 blocks the secretion of TNF-a from IFN-g-and endotoxinstimulated THP-1 macrophages. 3 We have, therefore, examined the influence of glatiramer on the ability of IFN-g to contain Listeria infection and on the activity of ampicillin and moxifloxacin to kill intraphagocytic bacteria in THP-1 macrophages. Glatiramer [CAS Registry no. 147 245-92-9; batch no. 242908102: average molecular weight, 7500 Da (limits, 4200 -16 350); amino acid content (molecular fraction) L-Glu, 0.139; L-Ala, 0.432; L-Tyr, 0.091; L-Lys, 0.338; total amino acid residue content, 87.9%; bacterial endotoxin content, < 0.25 endotoxin units/mg] was kindly received from Teva Pharmaceuticals Industries (Petah Tiqua, Israel). All experimental procedures and assay methods have been described in our previous publications. 4, 5 We used a concentration of glatiramer of 20 mg/L, which was both non-toxic (based on lactate dehydrogenase release) and effective in blocking the production of TNF-a in THP -1 cells. 3 Glatiramer (20 mg/L) did not influence the intrinsic antimicrobial activity of ampicillin or moxifloxacin towards L. monocytogenes, based on MIC determinations in broth [0.3 ± 0.1 and 0.5 ± 0.1 mg/L (arithmetic dilutions) for ampicillin and moxifloxacin, respectively]. Unstimulated cells produced only negligible amounts of TNF-a and glatiramer did not alter this behaviour. In contrast, the medium of cells exposed to IFN-g (100 units/mL; 24 h) contained 38.3 ± 6.0 ng/L of TNF-a, and this concentration was decreased by $ 2/3 in the presence of glatiramer. With infected cells, TNF-a production remained low in unstimulated cells and unaffected by the presence of glatiramer, whereas it amounted to 31.6 ± 1.2 ng/L (5 h post-phagocytosis) in IFNg-stimulated cells (24 h prior to infection). This production was again decreased by 2/3 if glatiramer was present. Glatiramer did not significantly modify the capacity of THP-1 macrophages to phagocytose L. monocytogenes. Figure 1 shows that glatiramer did not modify the growth of intracellular L. monocytogenes compared with untreated cells in the 24 h model (this model uses gentamicin at a concentration of 2 Â its MIC to prevent the extracellular growth of L. monocytogenes). No change was seen either in the 5 h model (data not shown). As previously described, 6 IFN-g impaired the intracellular growth of Figure 1 . Influence of glatiramer on the course of L. monocytogenes intracellular infection in J774 macrophages. Cells were exposed to L. monocytogenes for 1 h (phagocytosis) and then returned to fresh medium for 24 h before cell collection and enumeration of cell-associated bacteria. The growth of extracellular bacteria, which would otherwise occur after 5-6 h through the release of dying cells, was prevented by addition of gentamicin [2 mg/L (2ÂMIC); this concentration does not prevent the intracellular growth of L. monocytogenes, data not shown]. The four left blocks refer to cells unexposed to ampicillin and treated as follows: ctrl (control), no treatment; gtr (glatiramer), cells incubated with glatiramer (20 mg/L) for 24 h, and then maintained in the presence of the same concentration of glatiramer during the phagocytosis of L. monocytogenes as well as during the post-phagocytosis period (fresh solutions of glatiramer were used each time); IFN (IFN-g), cells exposed to IFN-g (100 units/mL) for 24 h before phagocytosis (IFN-g was not present during phagocytosis or during the post-phagocytosis period); gtr + IFN, cells treated as for the IFN group but with glatiramer present throughout the experiment as in the gtr group. The four right blocks refer to experiments with the same design but for which ampicillin (50 mg/L) was added during the 24 h post-phagocytosis period. The ordinate shows the change in bacterial counts from original inoculum (post-phagocytosis). All data points are the mean of three determinations ± S.D. Blocks with the same letters denote groups that are not significantly different from one another by one-way ANOVA (P>0.05). This experiment was performed twice with essentially similar results.
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